Brennan, Manna & Diamond
Listen. Solve. Empower.
Diversity & Inclusion
Client Alerts, News Articles, Blog Posts, & Multimedia
Everything you need to know about BMD and the industry.
HHS Addresses Drug Manufacturer Coupons on Out-of-Pocket Limits
May 25, 2020
On May 7, 2020, the US Department of Health and Human Services (“HHS”) announced their Notice of Benefit Parameters for 2021 in which HHS addressed the application of prescription drug manufacturer copay coupons towards a patient’s out-of-pocket limit. Under this guidance, HHS will permit, but not require, plans and insurers to count direct support offered to enrollees by drug manufacturers (i.e., coupons) for specific prescription drugs toward the annual limits on cost-sharing, regardless of whether a generic equivalent is available.
Kevin M. Cripe
Pondering Over Patient Billing: CARES Act and Provider Relief Fund Lead to More Questions
April 16, 2020
On April 11, 2020, HHS, along with the Department of Labor and Department of the Treasury, issued jointly prepared FAQs regarding the FFCRA, the CARES Act, and other health coverage issues. The FFCRA was enacted on March 18, 2020 and requires group health plans and health insurance issuers to provide benefits for certain items and services related to diagnostic testing for COVID-19. Additionally, plans and issuers must provide coverage without imposing any cost-sharing requirements (deductibles, copayments, and coinsurance), prior authorization, or other medical management requirements.
Amanda L. Waesch